2.8000
+0.1300
+(4.87%)
At close: January 30 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-81,410.0000
-51,061.0000
-34,554.0000
-40,081.0000
-39,836.0000
Investing Cash Flow
-51,265.0000
-57,116.0000
52,645.0000
-69,456.0000
9,053.0000
Financing Cash Flow
126,315.0000
82,780.0000
87.0000
120,806.0000
3,689.0000
End Cash Position
21,330.0000
26,585.0000
52,100.0000
34,012.0000
22,880.0000
Interest Paid Supplemental Data
2,155.0000
2,040.0000
1,614.0000
1,969.0000
2,470.0000
Capital Expenditure
-58.0000
-296.0000
-9.0000
-57.0000
-3,294.0000
Issuance of Capital Stock
127,004.0000
83,705.0000
--
122,231.0000
2,290.0000
Issuance of Debt
--
--
26,438.0000
--
--
Repayment of Debt
-26,350.0000
--
-26,350.0000
--
-514.0000
Repurchase of Capital Stock
-1,123.0000
-1,208.0000
-3.0000
-78.0000
--
Free Cash Flow
-81,468.0000
-51,357.0000
-34,563.0000
-40,138.0000
-43,130.0000
12/31/2020 - 4/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SCPH scPharmaceuticals Inc.
3.4500
+4.86%
CGEM Cullinan Therapeutics, Inc.
10.98
-2.40%
PLRX Pliant Therapeutics, Inc.
10.66
-0.74%
SLNO Soleno Therapeutics, Inc.
49.84
+0.97%
IKT Inhibikase Therapeutics, Inc.
1.9200
-31.43%
STTK Shattuck Labs, Inc.
1.2500
-5.30%
TRVI Trevi Therapeutics, Inc.
3.9000
+1.04%
NAMS NewAmsterdam Pharma Company N.V.
21.77
+4.76%
RGLS Regulus Therapeutics Inc.
1.0000
+3.09%
ALXO ALX Oncology Holdings Inc.
1.3050
-10.62%